Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Indocyanine Green in Rectal Cancer: CTRI/2026/05/110716 Clinical Landscape Report 2026
16 October 2026
CTRI/2026/05/110716 clinical landscape for Rectal Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ivonescimab in Lung Cancer: NCT07602855 Clinical Landscape Report 2026
16 October 2026
NCT07602855 clinical landscape for Lung Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Semaglutide (Novo Nordisk) in Obesity: NCT07599046 Clinical Landscape Report 2026
16 October 2026
NCT07599046 clinical landscape for Obesity: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Somatostatin Acetate in Rectal Cancer: NCT07605611 Clinical Landscape Report 2026
16 October 2026
NCT07605611 clinical landscape for Rectal Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
YMN-A02 (West China Hospital) in MSS/pMMR/MSI-L Colorectal Carcinoma: NCT07610707 Clinical Landscape Report 2026
16 October 2026
NCT07610707 clinical landscape for MSS/pMMR/MSI-L Colorectal Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white s…
9 min read
mRNA-4194 in Hereditary Nonpolyposis Colorectal Cancer: ISRCTN78380445 Clinical Landscape Report 2026
16 October 2026
ISRCTN78380445 clinical landscape for Hereditary Nonpolyposis Colorectal Cancer: endpoints, sponsor, phase, geography, readouts, asset context and developmen…
9 min read
Dapagliflozin in Diabetes Mellitus, Type 2: NCT07614230 Clinical Landscape Report 2026
16 October 2026
NCT07614230 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ertugliflozin pidolate in Diabetes Mellitus, Type 2: NCT07621380 Clinical Landscape Report 2026
16 October 2026
NCT07621380 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Cordycepin in Diabetes Mellitus, Type 2: TCTR20260601023 Clinical Landscape Report 2026
16 October 2026
TCTR20260601023 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Cetylpyridinium Chloride Hydrate in Periodontal Diseases: NCT07619729 Clinical Landscape Report 2026
16 October 2026
NCT07619729 clinical landscape for Periodontal Diseases: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Anlotinib Dihydrochloride in Esophageal Squamous Cell Carcinoma: NCT07627347 Clinical Landscape Report 2026
16 October 2026
NCT07627347 clinical landscape for Esophageal Squamous Cell Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white sp…
9 min read
Ropivacaine Hydrochloride in Colorectal Cancer: NCT07624916 Clinical Landscape Report 2026
16 October 2026
NCT07624916 clinical landscape for Colorectal Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.